It is clear that the findings in lung cancer differ from those observed in most other organ systems, or even other pulmonary diseases, such as emphysema [21], hyperoxia [22], and respiratory syncytial virus [23], where disease symptoms significantly worsen in the absence of NRF2. Here, NFE2L2 is linked to lung carcinoma.